Enanta

Eradivir

This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.

Panacos

This biotechnology company develops small molecule antiviral drugs to treat patients with human immunodeficiency virus and other serious infectious diseases.

Pharmacyclics

This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.

Eternygen

This biopharmaceutical company develops small molecule inhibitors targeting metabolic diseases, such as fatty liver and diabetes, for patients needing novel medical treatments.

Inventiva

This biopharmaceutical company develops oral small molecule therapies for patients with metabolic dysfunction-associated steatohepatitis and other fibrotic or metabolic diseases.

Atea Pharmaceuticals

This biopharmaceutical company develops oral antiviral therapies to treat patients with serious viral infections, including hepatitis C and hepatitis E.

Edesa Biotech

This biopharmaceutical company develops monoclonal antibody treatments for patients suffering from acute and chronic inflammatory and immune-related diseases.

Pharmasset

This biopharma company develops medicines for patients suffering from HIV, viral hepatitis, cancer, and inflammatory diseases.